Interventions should be systemic and coordinated interventions, including[@16558]: |
1. Equitable research collaborations with international organisations, favouring institutional international collaboration, beyond personal relationships between individuals. |
2. Support and involvement of citizens from the region with international clinical research expertise and leadership. |
3. A dedicated clinical research training curriculum. Enhancing and restructuring of the medical curriculum in universities to include clinical research syllabus for undergraduate and graduate studies. |
4. Durable local research capacity, including sustainable research networks – clinical Investigation centres, biobanks and core laboratories. |
5. Implementation of eHealth, starting with electronic medical records. |
6. Setting priorities favouring trials with objectives best aligned with local burden of diseases. |
7. Incentivising investments, from international pharmaceutical and biotech companies that would feed into the clinical research culture and infrastructure. |
8. Earmarking funding sources dedicated to clinical research capacity building and granting local priority research programs. |
9. Creating a favourable environment for local CROs and academic CROs operations. |
10. Mandating on-line registration and monitoring of all clinical trials conducted in the Region, ideally using existing international registries (clinicaltrials.gov and/or WHO). |